跳至主要内容
临床试验/NCT01770704
NCT01770704已完成不适用

Chinese Observation Study of the Clinical Management of Bipolar Disorder

AstraZeneca3 个研究点 分布在 1 个国家目标入组 520 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
520
试验地点
3
主要终点
Number of episodes (depression, mania, hypomania or mixed).

研究概览

简要总结

The objective of the ambispective cohort study is to describe clinical management and clinical outcomes related to bipolar disorder in China, and establish the factors associated with different management patterns and clinical outcomes, provide psychiatrists with reliable and up-to-date information on the disease.

研究设计

研究类型
Observational
观察模型
Cohort

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of subject informed consent.
  • Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder.
  • Patients who had at least one mood event( depression, mania, hypomania or mixed) according to DSM-IV TR definition during the 3 and 12 months prior to the beginning of the study.

排除标准

  • Inability to complete Patient Reported Outcomes (PROs) questionnaires.
  • Participation in an interventional clinical study in last 12 months.

结局指标

主要结局

Number of episodes (depression, mania, hypomania or mixed).

时间窗: Up to 21 months

次要结局

  • Treatments received for Bipolar Disorder: medication classes.(Up to 21 months)
  • Treatments received for Bipolar Disorder: medication time.(Up to 21 months)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验